Dr. Rivi Steinhart is a Patent Attorney in the Life Sciences Practice Group at Pearl Cohen’s Tel Aviv office. She has vast experience in global IP activities for generic, non-generic and biogeneric products, due diligence, FTO and patentability opinions, and drafting and prosecution of innovative patent applications.
Prior to joining Pearl Cohen, Rivi worked in the legal department at Teva, within the IP group, for 10 years. Rivi has a B.Pharm degree from the Hebrew University, M.Sc. in biotechnology (magna cum laude), Ph.D. in Neuroscience from Bar-Ilan University and Master of business administration, MBA, with specialization in bio-medical management (magna cum laude) from the College of Management Academic Studies.